POLIC Y SUMMARY

Overview
Percutaneous coronary intervention (PC I) may be indicated in the management of:
• Patients with acute coronary syndrome (e.g., acute myocardial infarction, unstable angina) •
Patients with a history of significant obstructive atherosclerotic disease • Patients with restenosis of a coronary artery previously treated with intracoronary stent or other revascularization procedure •
Patients with chronic angina • Patients with silent ischemia Generally PC I is not indicated for:
• Patients that can be managed medically • Right heart catheterization and insertion of a Swan-Ganz catheter are not generally medically necessary for a PC I and will be denied, unless medically necessary when performed incident to a diagnostic catheterization prior to the intervention • Standby services of a surgeon or anesthesiologist are not covered services •
Patients with stable coronary artery disease (C AD)
Indications for Intracoronary Ultrasound and Doppler Fractional Flow Reserve Studies
Intracoronary ultrasound may be separately covered when needed to assess the extent of coronary stenosis if equivocal on angiography, or when needed to assess the patency and integrity of a coronary artery post-intervention. Alternatively, intravascular doppler velocity and/or pressure derived coronary flow reserve measurement may be performed to assess the degree of stenosis within a vessel. Intracoronary ultrasound or fractional flow reserve measurement should be performed on an individual artery as clinically indicated. Both procedures are not considered medically necessary unless written documentation in the form of a procedure note is submitted to support medical necessity. Intracoronary ultrasound and doppler fractional flow reserve studies can be required in multivessel C AD.
Guidelines
A diagnostic cardiac catheterization to assess the nature of the lesion(s) prior to the intervention is a covered service. The diagnostic cardiac catheterization may be performed at any time prior to the PC I, including the same day as the PC I. Performance of a diagnostic cardiac catheterization and interventional procedure on the same day is increasingly the standard of practice. If the diagnostic catheterization is done within 30 days of the PC I, it is usually not necessary to repeat the catheterization unless there is a documented change in the patient's condition. While there may be reasons for delaying the interventional procedure (e.g., transfer from a community hospital to a tertiary center, excessive dye load, further treatment planning or evaluation of angiography, etc.), it is recommended that both procedures be performed during the same encounter when medically appropriate, with detailed discussion of benefits and risks of PC I. Separation of these procedures for the purpose of circumventing the multiple surgery pricing, or for the convenience of physician or hospital scheduling, is considered an inappropriate practice and may subject the services to review and denial for medical necessity. The decision to stage these procedures is deferred to the judgment of the interventional C ardiologist, and individualized only to the clinical needs of the patient (e.g., dye load already received, need to correlate findings with other test results, etc). Reasons for delaying an indicated percutaneous coronary intervention should be documented in the medical record. Unless there is a new clinical event, a change in symptomatology, abnormal examination or other test results, a repeat diagnostic catheterization within three months of the last diagnostic catheterization and prior to the percutaneous coronary intervention is generally not reimbursable and is considered not reasonable and necessary.
C laims for percutaneous coronary intervention must include the appropriate modifiers to identify which vessel is undergoing a specific procedure. Modifiers are identified as: LD (left anterior descending coronary artery), LC (left circumflex coronary artery), RC (right coronary artery), LM (left main artery) and RI (rasmus intermedius artery). Each intervention may only be billed as a single procedure regardless of the number of lesions treated within that vessel. If four or more stents are placed in a single vessel, then it would be considered an "unusual procedural service" and eligible for additional reimbursement equivalent to that of an additional treated vessel. Major coronary artery modifiers are required to be submitted with appropriate procedure codes as outlined in National C orrect C oding Initiative Policy Manual.
Prophylactic insertion of a temporary transvenous pacemaker, repositioning or replacement of catheters and administration of medications during the procedure are included in the procedure and are not separately billable. Right heart catheterization and insertion of a Swan-Ganz catheter are not generally medically necessary for a PC I and will be denied, unless medically necessary when performed incident to a diagnostic catheterization prior to the intervention. Standby services of a surgeon or anesthesiologist are not covered services.
Intracoronary injections of drugs during diagnostic or therapeutic procedures are considered to be part of the procedure and are not separately reimbursable.
APPLIC ABLE C ODES
The following list(s) of codes is provided for reference purposes only and may not be all inclusive. Listing of a code in this guideline does not imply that the service described by the code is a covered or non-covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply. Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (List separately in addition to code for primary procedure) (bundled code and will not be separately reimbursed)
92937
Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel 92938 Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (List separately in addition to code for primary procedure) (bundled code and will not be separately reimbursed)
92941
Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel 92943 Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; single vessel 92944 Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (List separately in addition to code for primary procedure) (bundled code and will not be separately reimbursed)
92973
Percutaneous transluminal coronary thrombectomy mechanical (List separately in addition to code for primary procedure)
92974
Transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy (List separately in addition to code for primary procedure) Codes 92920, 92924, 92928, 92933, 92937, 92941, 92943, C9600, C9601, C9602, C9603,  C9604, C9605, C9606, C9607, HCPCS Codes 92920, 92924, 92928, 92933, 92937, 92941, 92943, C9600, C9601, C9602, C9603,  C9604, C9605, C9606, C9607, HCPCS Codes 92920, 92924, 92928, 92933, 92937, 92941, 92943, C9600, C9601, C9602, C9603,  C9604, C9605, C9606, C9607, T, DE, FL,  GA, HI, IA, ID, IL, IN, KS, KY, LA,  MA, MD, ME, MI, MO, MS, MT, NC ,  ND, NE, NH, NJ, NM, NV, OH, OK,  OR, PA, RI, SC , SD, TN, TX, UT, VA,  VT, WA, WI, WV, Benefit coverage for health services is determined by the member specific benefit plan document* and applicable laws that may require coverage for a specific service. The member specific benefit plan document identifies which services are covered, which are excluded, and which are subject to limitations. In the event of a conflict, the member specific benefit plan document supersedes the Medicare Advantage Policy Guidelines.
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